Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer

In the evolving molecular treatment landscape of metastatic colorectal cancer (mCRC), the identification of druggable alterations is pivotal to achieve the best therapeutic opportunity for each patient. Because the number of actionable targets is expanding, there is the need to timely detect their p...

Descripción completa

Detalles Bibliográficos
Autores principales: Patelli, Giorgio, Mauri, Gianluca, Tosi, Federica, Amatu, Alessio, Bencardino, Katia, Bonazzina, Erica, Pizzutilo, Elio Gregory, Villa, Federica, Calvanese, Gabriele, Agostara, Alberto Giuseppe, Stabile, Stefano, Ghezzi, Silvia, Crisafulli, Giovanni, Di Nicolantonio, Federica, Marsoni, Silvia, Bardelli, Alberto, Siena, Salvatore, Sartore-Bianchi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643999/
https://www.ncbi.nlm.nih.gov/pubmed/37436743
http://dx.doi.org/10.1158/1078-0432.CCR-23-0079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643999/
https://www.ncbi.nlm.nih.gov/pubmed/37436743
http://dx.doi.org/10.1158/1078-0432.CCR-23-0079

Ejemplares similares